Steward Partners Investment Advisory, LLC Spero Therapeutics, Inc. Transaction History

Steward Partners Investment Advisory, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 08, 2022	SELL	$13.09 - $18.77 $13,090 - $18,770	-1,000 Closed	0 $0
Q2 2021 Aug 13, 2021	SELL	$12.22 - $15.79 $14,664 - $18,948	-1,200 Reduced 54.55%	1,000 $14,000
Q1 2021 May 14, 2021	BUY	$13.23 - $21.48 $3,969 - $6,444	300 Added 15.79%	2,200 $32,000
Q4 2020 Feb 11, 2021	SELL	$11.65 - $22.07 $17,475 - $33,105	-1,500 Reduced 44.12%	1,900 $37,000
Q3 2020 Oct 30, 2020	SELL	$8.96 - $14.12 $25,088 - $39,536	-2,800 Reduced 45.16%	3,400 $38,000
Q2 2020 Aug 06, 2020	BUY	$7.27 - $14.18 $45,074 - $87,916	6,200 New	6,200 $84,000

13.9M

200

200

Ticker SPRO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 35,067,500
Market Cap $33.3M
Description
Spero Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on identifying, developing, and commercializing treatments for multi-drug resistant (MDR) bacterial infections and rare diseases in the United States. The company's product candidates include tebipenem pivoxil hydrobromide (HBr), an oral carbapenem-class antibiotic to ...

Get notified when there are updates to the investment portfolio of Steward Partners Investment Advisory, LLC, based on Form 13F filings with the SEC.

Stay updated on Steward Partners Investment Advisory, LLC with notifications on news.